Elite Athletes: Trunk Mobility, Lower Extremity Flexibility, and Functional Balance Across Sports
NCT ID: NCT07326046
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2025-03-01
2025-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study found that athletes with PFPS demonstrated a higher dynamic Q angle, lower core extension and lateral endurance, reduced hip flexor and iliotibial band flexibility, and lower functional scores compared with controls. Regression analyses indicated that hip flexor tightness and functional capacity were significant predictors of the dynamic Q angle in the PFPS group. These findings suggest that PFPS in adolescent athletes is a multidimensional condition influenced by proximal endurance, flexibility, and dynamic alignment rather than isolated knee-level factors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynamic Q Angle and Core Endurance in Adolescent Athletes With Patellofemoral Pain Syndrome
NCT07328750
Core Stabilization for the Treatment of Anterior Knee Pain
NCT02123602
Training Induced Reduction of Lower-limb Joint Loads During Locomotion in Obese Children
NCT02545764
Compatibility of Different Injury Prevention Exercises in Athletes
NCT02311062
Ilium Mobilization in Patellofemoral Pain Syndrome Treatment
NCT05708495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This cross-sectional observational study was conducted to examine the relationships among dynamic Q angle, core muscle endurance, hip and lower extremity flexibility, and functional status in elite adolescent athletes with and without PFPS. A total of 75 track-and-field athletes aged 15-18 years were included. Participants were allocated into two groups: athletes diagnosed with PFPS and healthy controls. Dynamic Q angle was assessed using digital two-dimensional video analysis of the step-down test. Core endurance was evaluated using the McGill endurance test battery (flexor, extensor, and lateral plank tests). Flexibility was assessed using the Straight Leg Raise, Modified Thomas, and Ober tests. Functional status was measured with the Lower Extremity Functional Scale (LEFS). All side-dependent measurements were analyzed on the index limb (symptomatic side in the PFPS group and matched limb in controls).
Group differences and correlations among variables were examined, and multiple regression analyses were performed to identify predictors of the dynamic Q angle. The results demonstrated that athletes with PFPS exhibited a significantly higher dynamic Q angle, reduced core extension and lateral endurance, decreased hip flexor and iliotibial band flexibility, and lower functional scores compared with controls. In the PFPS group, hip flexor tightness and functional capacity were significant predictors of the dynamic Q angle, explaining a substantial proportion of its variance.
These findings indicate that PFPS in adolescent athletes represents a multidimensional biomechanical syndrome characterized by the interaction of proximal stability, flexibility restrictions, and dynamic alignment alterations. The study highlights the clinical importance of comprehensive assessment strategies that incorporate core endurance, hip flexibility, and functional performance measures, rather than focusing solely on isolated knee-level factors. The results may contribute to the development of targeted prevention and rehabilitation strategies for adolescent athletes at risk of PFPS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PFPS Group/ Cohort
Adolescent elite athletes diagnosed with patellofemoral pain syndrome.
No interventions assigned to this group
Control Group
Healthy adolescent elite athletes without anterior knee pain or lower extremity complaints.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum 2 years of regular training participation
* Training at least 5 days per week
* Ability to complete all assessment procedures
* PFPS group: history of anterior knee pain associated with activity, positive clinical provocation tests, and AKPS score \< 80
* Control group: no history of lower extremity pain or functional limitation
Exclusion Criteria
* Neurological, rheumatological, or systemic disease
* Structural deformity of the hip, knee, or ankle
* Ongoing orthopedic rehabilitation or regular analgesic / anti-inflammatory medication use
* Any condition preventing participation in the tests or introducing measurement bias
15 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eastern Mediterranean University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Burçin Uğur Tosun
Principal Investigator PhD Physiotherapist Burcin Ugur Tosun
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Burcin Ugur Tosun
Famagusta, , Cyprus
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEF-BALANCE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.